FDA inspections of drug manufacturing facilities in the United States and overseas declined well below pre-pandemic levels between 2020 and 2022, according to a new study in Health Affairs.
On November 28, 2023, FDA issued an alert detailing potential harms tied to the use of brand-name and generic versions of certain antiseizure medications.
Imatinib is one of the most effective cancer drugs available, but many patients cannot afford the steep price.
The official 2024 immunization schedules with new vaccine recommendations for children and adolescents and for adults are now available from CDC. The updated schedules are being published ahead of time.
FDA granted marketing approval to the first diagnostic test for chlamydia and gonorrhea with at-home sample collection.